BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021GlobeNewsWire • 09/17/20
Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine DevelopmentThe Motley Fool • 09/15/20
Covid Roundup: BioNTech Boosts Funding; Novavax Boosts ManufacturingInvestors Business Daily • 09/15/20
BioNTech shares jump premarket on news of 375 million euros in German funding for COVID-19 vaccineMarket Watch • 09/15/20
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162GlobeNewsWire • 09/15/20
Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical TrialThe Motley Fool • 09/13/20
Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EUThe Motley Fool • 09/09/20
Pfizer, BioNTech Ink Covid Vaccine Deal With EU, Post Positive Trial DataInvestors Business Daily • 09/09/20
BioNTech, Pfizer expect clinical 'answer' on coronavirus vaccine in late OctoberMarket Watch • 09/09/20
Moderna, BioNTech, Pfizer stocks rally after AstraZeneca COVID-19 vaccine trial is reportedly haltedMarket Watch • 09/09/20
Pfizer and BioNTech Announce Data From Preclinical Studies of mRNA-Based Vaccine Candidate Against COVID-19GlobeNewsWire • 09/09/20
Pfizer, BioNTech conclude talks over supplying EU with SARS-CoV-2 vaccine candidateMarket Watch • 09/09/20
Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2GlobeNewsWire • 09/09/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20